Updates are available Correction dated 2025-04-15
Click to view Correction: https://doi.org/10.1038/s41591-025-03706-7
-
Authors
Sun, Zeguo
Yi, Zhengzi
Wei, Chengguo https://orcid.org/0000-0002-7940-8310
Wang, Wenlin
Ren, Tianyuan
Cravedi, Paolo https://orcid.org/0000-0001-7837-0923
Tedla, Fasika https://orcid.org/0000-0003-2695-9570
Ward, Stephen C.
Azeloglu, Evren https://orcid.org/0000-0001-6137-109X
Schrider, Daniel R. https://orcid.org/0000-0001-5249-4151
Li, Yun https://orcid.org/0000-0002-9275-4189
Khan, Atlas https://orcid.org/0000-0002-6651-2725
Zanoni, Francesca https://orcid.org/0000-0001-9567-6713
Fu, Jia https://orcid.org/0000-0002-8280-3813
Ali, Sumaria
Liu, Shun
Liang, Deguang
Liu, Tong
Li, Hong https://orcid.org/0000-0001-5731-5335
Xi, Caixia
Vy, Thi Ha
Mosoyan, Gohar
Sun, Quan https://orcid.org/0000-0001-8324-2803
Kumar, Ashwani https://orcid.org/0000-0002-0086-7398
Zhang, Zhongyang https://orcid.org/0000-0002-2521-3884
Farouk, Samira
Campell, Kirk
Ochando, Jordi https://orcid.org/0000-0001-7037-1681
Lee, Kyung https://orcid.org/0000-0002-9756-1765
Coca, Steve
Xiang, Jenny
Connolly, Patricia
Gallon, Lorenzo https://orcid.org/0000-0002-6094-1027
O’Connell, Philip J.
Colvin, Robert https://orcid.org/0000-0002-4493-4150
Menon, Madhav C.
Nadkarni, Girish https://orcid.org/0000-0001-6319-4314
He, John C. https://orcid.org/0000-0002-1502-2849
Kraft, Monica
Jiang, Xuejun
Zhang, Xuewu https://orcid.org/0000-0002-3634-6711
Kiryluk, Krzysztof https://orcid.org/0000-0002-5047-6715
Cherukuri, Aravind https://orcid.org/0000-0002-8649-2901
Lakkis, Fadi G.
Zhang, Weiguo
Chen, Shu-hsia
Heeger, Peter S.
Zhang, Weijia https://orcid.org/0009-0005-0151-4200
- License Information
-
More Information
Article History
Received: 19 February 2024
Accepted: 4 February 2025
First Online: 10 March 2025
Change Date: 15 April 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41591-025-03706-7
Competing interests
: Weijia Zhang reports personal fees from VericiDx and reports the patents (Patents US Provisional Patent Application F&R ref. 27527-0134P01, serial no. 61/951,651, filed March 2014; Method for identifying kidney allograft recipients at risk for chronic injury; US Provisional Patent Application: Methods for Diagnosing Risk of Renal Allograft Fibrosis and Rejection (miRNA); US Provisional Patent Application: Method for Diagnosing Subclinical Acute Rejection by RNA Sequencing Analysis of a Predictive Gene Set; US Provisional Patent Application: Pretransplant prediction of post- transplant acute rejection). M.C.M. receives research support from Natera. P. Cravedi is a consultant for Chinook therapeutics. L.G. is the non-executive Director and Chair of the science advisory board for Verici. The other investigators have no financial interest to declare.
